OrganiGram Holdings is trading 5.5% down at $1.01, with no clear company-specific catalyst identified. - Its 2026 investor-session premiere is scheduled for 4:00 p.m. ET on September 30, covering growth, margins, cash generation, and capital allocation. The announcement reports no new financial or operational developments and is not linked to the price move. - Major U.S. indices were mixed to higher, and available searches found no cannabis-sector catalyst. The reason for the decline remains unclear.